Cubist Systematic Strategies’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-40
Closed -$129 3282
2024
Q4
$129 Sell
40
-16,804
-100% -$59.2K ﹤0.01% 2903
2024
Q3
$52.7K Sell
16,844
-14,399
-46% -$46.9K ﹤0.01% 2762
2024
Q2
$98.1K Buy
+31,243
New +$115K ﹤0.01% 2632
2024
Q1
Sell
-3,466
Closed -$20.5K 4097
2023
Q4
$20.5K Buy
+3,466
New +$13.9K ﹤0.01% 3348

Other funds holding MURA

Cubist Systematic Strategies's MURA Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Mural Oncology (MURA) in Q1 2025, closing a stake of 40 shares — an estimated $129 sold.

Cubist Systematic Strategies first reported a position in MURA in Q4 2023 and held it in 4 quarters. The position peaked at $98.1K in Q2 2024. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Mural Oncology position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 40 Mural Oncology shares in Q1 2025, an estimated $129.
  • Cubist Systematic Strategies first reported a position in Mural Oncology in Q4 2023 and held it in 4 quarters.
  • Cubist Systematic Strategies's Mural Oncology position peaked at $98.1K in Q2 2024.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.